+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
911417-87-3,MFCD23098791
Catalog No.:AA003ADV

911417-87-3 | Slx-2119

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
99%
in stock  
$6.00   $4.00
- +
5mg
99%
in stock  
$8.00   $6.00
- +
10mg
99%
in stock  
$11.00   $8.00
- +
25mg
99%
in stock  
$19.00   $14.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA003ADV
Chemical Name:
Slx-2119
CAS Number:
911417-87-3
Molecular Formula:
C26H24N6O2
Molecular Weight:
452.5078
MDL Number:
MFCD23098791
SMILES:
CC(NC(=O)COc1cccc(c1)c1nc(Nc2ccc3c(c2)cn[nH]3)c2c(n1)cccc2)C
Properties
Computed Properties
 
Complexity:
678  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
7  
XLogP3:
4.8  

Downstream Synthesis Route
911417-62-4   
CASUnavailable 
  911417-87-3 

[1]CurrentPatentAssignee:NANOTERRA,INC.-WO2008/54599,2008,A2Locationinpatent:Page/Pagecolumn147

[2]CurrentPatentAssignee:NANOTERRA,INC.-WO2010/104851,2010,A1Locationinpatent:Page/Pagecolumn143

[3]CurrentPatentAssignee:NANOTERRA,INC.-WO2006/105081,2006,A2Locationinpatent:Page/Pagecolumn132

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,A

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,ALocationinpatent:Paragraph0018;0035;0054-0056;0064;0072

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,A

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,A

Literature

Title: Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20081001

Title: Boerma, M., et al. Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase. Blood Coagul Fibrinolysis. 2008 Oct;19(7):709-18.

Title: Lee, J.H., et al. Selective ROCK2 Inhibition In Focal Cerebral Ischemia. Ann Clin Transl Neurol. 2014 Jan 1;1(1):2-14.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 911417-87-3
911417-62-4

911417-62-4

 2109704-99-4

2109704-99-4
Building Blocks
More >
Tags:911417-87-3 Molecular Formula|911417-87-3 MDL|911417-87-3 SMILES|911417-87-3 Slx-2119
Catalog No.: AA003ADV
911417-87-3,MFCD23098791
911417-87-3 | Slx-2119
Pack Size： 1mg
Purity： 99%
in stock
$6.00 $4.00
Pack Size： 5mg
Purity： 99%
in stock
$8.00 $6.00
Pack Size： 10mg
Purity： 99%
in stock
$11.00 $8.00
Pack Size： 25mg
Purity： 99%
in stock
$19.00 $14.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA003ADV
Chemical Name: Slx-2119
CAS Number: 911417-87-3
Molecular Formula: C26H24N6O2
Molecular Weight: 452.5078
MDL Number: MFCD23098791
SMILES: CC(NC(=O)COc1cccc(c1)c1nc(Nc2ccc3c(c2)cn[nH]3)c2c(n1)cccc2)C
Properties
Complexity: 678  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 3  
Rotatable Bond Count: 7  
XLogP3: 4.8  
Downstream Synthesis Route
911417-62-4   
CASUnavailable 
  911417-87-3 

[1]CurrentPatentAssignee:NANOTERRA,INC.-WO2008/54599,2008,A2Locationinpatent:Page/Pagecolumn147

[2]CurrentPatentAssignee:NANOTERRA,INC.-WO2010/104851,2010,A1Locationinpatent:Page/Pagecolumn143

[3]CurrentPatentAssignee:NANOTERRA,INC.-WO2006/105081,2006,A2Locationinpatent:Page/Pagecolumn132

2411027-08-0    911417-87-3 

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,A

2121561-41-7    19335-11-6    911417-87-3 

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,ALocationinpatent:Paragraph0018;0035;0054-0056;0064;0072

75726-96-4    911417-87-3 

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,A

1208966-76-0    911417-87-3 

[1]CurrentPatentAssignee:SHANGHAIINSTITUEOFTECHNOLOGY-CN106916145,2017,A

Literature fold

Title: Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis20081001

Title: Boerma, M., et al. Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase. Blood Coagul Fibrinolysis. 2008 Oct;19(7):709-18.

Title: Lee, J.H., et al. Selective ROCK2 Inhibition In Focal Cerebral Ischemia. Ann Clin Transl Neurol. 2014 Jan 1;1(1):2-14.

Related Products of of 911417-87-3
911417-62-4
911417-62-4
2109704-99-4
2109704-99-4
Building Blocks More >
862728-59-4
862728-59-4
Toluene-4-sulfonic acid 2-cyclopropoxy-ethyl ester
AA003AJO | MFCD22209886
10466-28-1
10466-28-1
Alpha-MSH (free acid)
AA003APN | MFCD00167725
5057-99-8
5057-99-8
(+/-)-Trans-1,2-cyclopentanediol
AA003AVC | MFCD00082582
6974-77-2
6974-77-2
1-Bromo-3-chloro-2-methylpropane
AA003AYF | MFCD00000955
147-82-0
147-82-0
2,4,6-Tribromoaniline
AA003B1F | MFCD00007634
121-86-8
121-86-8
2-Chloro-4-nitrotoluene
AA003B4E | MFCD00007210
63024-77-1
63024-77-1
3-(Chloromethyl)benzoyl chloride
AA003B7H | MFCD00000682
21150-12-9
21150-12-9
2-Hydroxy-2-(3-methoxyphenyl)acetic acid
AA003BBH | MFCD00041017
1072946-53-2
1072946-53-2
2-(Bromomethyl)-3,4,5-trichlorophenylboronic acid
AA003BHA | MFCD11053838
60043-43-8
60043-43-8
(2-Methoxyethoxymethyl)triethylammonium chloride
AA003BKX | MFCD00059973
Submit
© 2017 AA BLOCKS, INC. All rights reserved.